FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199372004> ?p ?o ?g. }

• W3199372004 endingPage "1307" @default.
• W3199372004 startingPage "1305" @default.
• W3199372004 abstract "ImmunotherapyVol. 13, No. 16 EditorialFuture applications of and prospects for near-IR photoimmunotherapy: benefits and differences compared with photodynamic and photothermal therapyHisataka Kobayashi & Peter L ChoykeHisataka Kobayashi *Author for correspondence: Tel.: +1 240 858 3069; E-mail Address: kobayash@mail.nih.govhttps://orcid.org/0000-0003-1019-4112Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USASearch for more papers by this author & Peter L Choyke https://orcid.org/0000-0003-1086-8826Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USASearch for more papers by this authorPublished Online:13 Sep 2021https://doi.org/10.2217/imt-2021-0216AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: antibody therapeuticscancer immunologymolecular immunologyReferences1. Kobayashi H, Choyke PL. Near-infrared photoimmunotherapy of cancer. Acc. Chem. Res. 52(8), 2332–2339 (2019).Crossref, Medline, CAS, Google Scholar2. Kobayashi H, Griffiths GL, Choyke PL. Near-infrared photoimmunotherapy: photoactivatable antibody-drug conjugates (ADCs). Bioconjug. Chem. 31(1), 28–36 (2020).Crossref, Medline, CAS, Google Scholar3. Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat. Med. 17(12), 1685–1691 (2011).Crossref, Medline, CAS, Google Scholar4. ClinicalTrials ASP-1929 photoimmunotherapy (PIT) study in recurrent head/neck cancer for patients who have failed at least two lines of therapy (2021). https://clinicaltrials.gov/ct2/show/NCT03769506Google Scholar5. Sato K, Ando K, Okuyama S et al. Photoinduced ligand release from a silicon phthalocyanine dye conjugated with monoclonal antibodies: a mechanism of cancer cell cytotoxicity after near-infrared photoimmunotherapy. ACS Cent. Sci. 4(11), 1559–1569 (2018).Crossref, Medline, CAS, Google Scholar6. Ogawa M, Tomita Y, Nakamura Y et al. Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity. Oncotarget 8(6), 10425–10436 (2017).Crossref, Medline, Google Scholar7. Nagaya T, Friedman J, Maruoka Y et al. Host immunity following near-infrared photoimmunotherapy is enhanced with PD-1 checkpoint blockade to eradicate established antigenic tumors. Cancer Immunol. Res. 7(3), 401–413 (2019).Crossref, Medline, CAS, Google Scholar8. Okada R, Kato T, Furusawa A et al. Local depletion of immune checkpoint ligand CTLA4 expressing cells in tumor beds enhances antitumor host immunity. Adv. Ther. (Weinh.) 4(5), 2000269 (2021).Crossref, Medline, CAS, Google Scholar9. Sato K, Sato N, Xu B et al. Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy. Sci. Transl. Med. 8(352), 352ra110 (2016).Crossref, Medline, Google Scholar10. Kato T, Wakiyama H, Furusawa A, Choyke PL, Kobayashi H. Near infrared photoimmunotherapy; a review of targets for cancer therapy. Cancers (Basel) 13(11), 2535 (2021).Crossref, Medline, Google Scholar11. Nagaya T, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Kobayashi H. Endoscopic near infrared photoimmunotherapy using a fiber optic diffuser for peritoneal dissemination of gastric cancer. Cancer Sci. 109(6), 1902–1908 (2018).Crossref, Medline, CAS, Google Scholar12. Sato K, Nagaya T, Mitsunaga M, Choyke PL, Kobayashi H. Near infrared photoimmunotherapy for lung metastases. Cancer Lett. 365(1), 112–121 (2015).Crossref, Medline, CAS, Google Scholar13. Sano K, Nakajima T, Choyke PL, Kobayashi H. Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. ACS Nano 7(1), 717–724 (2013).Crossref, Medline, CAS, Google Scholar14. Mitsunaga M, Nakajima T, Sano K, Choyke PL, Kobayashi H. Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate. Bioconjug. Chem. 23(3), 604–609 (2012).Crossref, Medline, Google Scholar15. Maruoka Y, Furusawa A, Okada R et al. Combined CD44- and CD25-targeted near-infrared photoimmunotherapy selectively kills cancer and regulatory T cells in syngeneic mouse cancer models. Cancer Immunol. Res. 8(3), 345–355 (2020).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByTrastuzumab‐based near‐infrared photoimmunotherapy in xenograft mouse of breast cancer18 October 2022 | Cancer Medicine, Vol. 12, No. 4 Vol. 13, No. 16 Follow us on social media for the latest updates Metrics Downloaded 108 times History Received 8 August 2021 Accepted 25 August 2021 Published online 13 September 2021 Published in print November 2021 Information© 2021 Future Medicine LtdKeywordsantibody therapeuticscancer immunologymolecular immunologyAuthor contributionsH Kobayashi and PL Choyke contributed equally to this article.Financial & competing interests disclosureThis work was supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH (grant no. ZIA BC 011513). The authors are inventors of US government patents on NIR-PIT that have been licensed to Rakuten Medical Inc. The authors do not receive direct payments from Rakuten Medical Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download" @default.
• W3199372004 created "2021-09-27" @default.
• W3199372004 creator A5082080836 @default.
• W3199372004 creator A5090173640 @default.
• W3199372004 date "2021-11-01" @default.
• W3199372004 modified "2023-10-05" @default.
• W3199372004 title "Future applications of and prospects for near-IR photoimmunotherapy: benefits and differences compared with photodynamic and photothermal therapy" @default.
• W3199372004 cites W1983692618 @default.
• W3199372004 cites W1999082469 @default.
• W3199372004 cites W2050753051 @default.
• W3199372004 cites W2137481693 @default.
• W3199372004 cites W2513056697 @default.
• W3199372004 cites W2565382901 @default.
• W3199372004 cites W2799279071 @default.
• W3199372004 cites W2900131693 @default.
• W3199372004 cites W2913388824 @default.
• W3199372004 cites W2964086043 @default.
• W3199372004 cites W2971630275 @default.
• W3199372004 cites W2998887723 @default.
• W3199372004 cites W3133091495 @default.
• W3199372004 cites W3164133397 @default.
• W3199372004 doi "https://doi.org/10.2217/imt-2021-0216" @default.
• W3199372004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34514846" @default.
• W3199372004 hasPublicationYear "2021" @default.
• W3199372004 type Work @default.
• W3199372004 sameAs 3199372004 @default.
• W3199372004 citedByCount "2" @default.
• W3199372004 countsByYear W31993720042022 @default.
• W3199372004 countsByYear W31993720042023 @default.
• W3199372004 crossrefType "journal-article" @default.
• W3199372004 hasAuthorship W3199372004A5082080836 @default.
• W3199372004 hasAuthorship W3199372004A5090173640 @default.
• W3199372004 hasConcept C121608353 @default.
• W3199372004 hasConcept C126322002 @default.
• W3199372004 hasConcept C143998085 @default.
• W3199372004 hasConcept C171250308 @default.
• W3199372004 hasConcept C178790620 @default.
• W3199372004 hasConcept C182606246 @default.
• W3199372004 hasConcept C185592680 @default.
• W3199372004 hasConcept C192562407 @default.
• W3199372004 hasConcept C2781323092 @default.
• W3199372004 hasConcept C502942594 @default.
• W3199372004 hasConcept C71924100 @default.
• W3199372004 hasConceptScore W3199372004C121608353 @default.
• W3199372004 hasConceptScore W3199372004C126322002 @default.
• W3199372004 hasConceptScore W3199372004C143998085 @default.
• W3199372004 hasConceptScore W3199372004C171250308 @default.
• W3199372004 hasConceptScore W3199372004C178790620 @default.
• W3199372004 hasConceptScore W3199372004C182606246 @default.
• W3199372004 hasConceptScore W3199372004C185592680 @default.
• W3199372004 hasConceptScore W3199372004C192562407 @default.
• W3199372004 hasConceptScore W3199372004C2781323092 @default.
• W3199372004 hasConceptScore W3199372004C502942594 @default.
• W3199372004 hasConceptScore W3199372004C71924100 @default.
• W3199372004 hasFunder F4320337351 @default.
• W3199372004 hasIssue "16" @default.
• W3199372004 hasLocation W31993720041 @default.
• W3199372004 hasLocation W31993720042 @default.
• W3199372004 hasOpenAccess W3199372004 @default.
• W3199372004 hasPrimaryLocation W31993720041 @default.
• W3199372004 hasRelatedWork W2073514222 @default.
• W3199372004 hasRelatedWork W2256492013 @default.
• W3199372004 hasRelatedWork W2360420977 @default.
• W3199372004 hasRelatedWork W2364896477 @default.
• W3199372004 hasRelatedWork W2930647891 @default.
• W3199372004 hasRelatedWork W2981548320 @default.
• W3199372004 hasRelatedWork W3099428474 @default.
• W3199372004 hasRelatedWork W3116150627 @default.
• W3199372004 hasRelatedWork W4387326986 @default.
• W3199372004 hasRelatedWork W564069220 @default.
• W3199372004 hasVolume "13" @default.
• W3199372004 isParatext "false" @default.
• W3199372004 isRetracted "false" @default.
• W3199372004 magId "3199372004" @default.
• W3199372004 workType "article" @default.